Covidien files patent infringement lawsuit against Ethicon Endo-Surgery

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that, through its family of companies, a lawsuit was filed in the United States District Court for the District of Connecticut against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, relating to Ethicon’s Harmonic® line of ultrasonic surgical products.

“We will vigorously protect our innovations with our intellectual property”

“We will vigorously protect our innovations with our intellectual property,” said Ralph Corradi, Vice President, Endomechanical Franchise, Covidien.

The lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by many of Ethicon’s Harmonic® devices. Many of these same devices were found to infringe two of the same patents in a prior suit in the same court. A December 2009 appeals court decision in the prior case permitted the filing of this new lawsuit following dismissal of the prior suit on other grounds. The new suit asks the federal court to enjoin Ethicon from continuing to make and sell the Harmonic® devices named in the lawsuit, and to grant damages for these infringements.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Stem-cell implants restore vision in patients with corneal stem cell deficiency